Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates

Khalid Abdalla Ali Abdel Rahim 1 , 2 , * and Ahmed Mohamed Ali Mohamed 3
Authors Information
1 Botany and Microbiology Department, College of Science, King Saud University, Saudi Arabi
2 Botany Department, Faculty of Science, Sohag University, Sohag, Egypt
3 Department of Microbiology, College of Health Science, University of Dammam, Hafr Al Batin, Saudi Arabia
Article information
  • Jundishapur Journal of Microbiology: November 01, 2014, 7 (11); e17114
  • Published Online: November 1, 2014
  • Article Type: Research Article
  • Received: February 16, 2014
  • Revised: March 2, 2014
  • Accepted: April 14, 2014
  • DOI: 10.5812/jjm.17114

To Cite: Ali Abdel Rahim K A, Mohamed Ali Mohamed A. Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates, Jundishapur J Microbiol. 2014 ; 7(11):e17114. doi: 10.5812/jjm.17114.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Palucha A, Mikiewicz B, Hryniewicz W, Gniadkowski M. Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother. 1999; 44(4): 489-99[PubMed]
  • 2. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001; 39(6): 2206-12[DOI][PubMed]
  • 3. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection. 1989; 17(5): 316-21[PubMed]
  • 4. DeSirot D, Champs C, Chanal C, Labia F, Darfeuille-Michaud A. Translocation of antibiotics resistance determinants including extended spectrum -lactamase between conjugative plasmids of Klebsiella pneumonia and Escherichia coli. Antimicrob Agents and Chemother. 1989; 34(1): 1576-81
  • 5. Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med. 1971; 74(5): 657-64[PubMed]
  • 6. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4): 933-51[DOI][PubMed]
  • 7. Rice LB, Bonomo RA. beta -Lactamases: which ones are clinically important? Drug Resist Updat. 2000; 3(3): 178-89[DOI][PubMed]
  • 8. Moland ES, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother. 2002; 46(12): 3837-42[PubMed]
  • 9. Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003; 47(4): 273-95[PubMed]
  • 10. Clinical and Laboratory Standards Institute . Informational Supplement,. 2006;
  • 11. MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect. 2002; 8(11): 715-24[PubMed]
  • 12. Hansotia JB, Agarwal V, Pathak AA, Saoji AM. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res. 1997; 105: 158-61[PubMed]
  • 13. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res. 2007; 125(2): 173-8[PubMed]
  • 14. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection of -lactamases in nosocomial gram negative clinical isolates. Indian J Med Microbiol. 2004; 22(4): 247-50[PubMed]
  • 15. Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol. 2005; 23(1): 20-3[PubMed]
  • 16. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol. 1997; 35(8): 2061-7[PubMed]
  • 17. Shannon K, Stapleton P, Xiang X, Johnson A, Beattie H, El Bakri F, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol. 1998; 36(10): 3105-10[PubMed]
  • 18. Gupta V, Singla N, Chander J. Detection of ESBLs using third & fourth generation cephalosporins in double disc synergy test. Indian J Med Res. 2007; 126(5): 486-7[PubMed]
  • 19. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother. 2000; 45(6): 895-8[PubMed]
  • 20. Romero ED, Padilla TP, Hernandez AH, Grande RP, Vazquez MF, Garcia IG, et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis. 2007; 59(4): 433-7[DOI][PubMed]
  • 21. Kuo KC, Shen YH, Hwang KP. Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect. 2007; 40(3): 248-54[PubMed]
  • 22. Hosoglu S, Gundes S, Kolayli F, Karadenizli A, Demirdag K, Gunaydin M, et al. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. Indian J Med Microbiol. 2007; 25(4): 346-50[PubMed]
  • 23. Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol (Paris). 2008; 56(5): 319-25[DOI][PubMed]
  • 24. Xiong Z, Zhu D, Zhang Y, Wang F. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]. Zhonghua Yi Xue Za Zhi. 2002; 82(21): 1476-9[PubMed]
  • 25. Goossens H, Mystic Study Group . MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis. 2001; 41(4): 183-9[PubMed]
  • 26. Duttaroy B, Mehta S. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J Pathol Microbiol. 2005; 48(1): 45-8[PubMed]
  • 27. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22(3): 172-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments